Cargando…
PHB2 Alleviates Neurotoxicity of Prion Peptide PrP(106–126) via PINK1/Parkin-Dependent Mitophagy
Prion diseases are a group of neurodegenerative diseases characterized by mitochondrial dysfunction and neuronal death. Mitophagy is a selective form of macroautophagy that clears injured mitochondria. Prohibitin 2 (PHB2) has been identified as a novel inner membrane mitophagy receptor that mediates...
Autores principales: | Zheng, Xiaohui, Liu, Kun, Xie, Qingqing, Xin, Hangkuo, Chen, Wei, Lin, Shengyu, Feng, Danqi, Zhu, Ting |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10647768/ https://www.ncbi.nlm.nih.gov/pubmed/37958902 http://dx.doi.org/10.3390/ijms242115919 |
Ejemplares similares
-
Cardiolipin externalization mediates prion protein (PrP) peptide 106–126-associated mitophagy and mitochondrial dysfunction
por: Yang, Dongming, et al.
Publicado: (2023) -
PINK1-parkin-mediated neuronal mitophagy deficiency in prion disease
por: Li, Jie, et al.
Publicado: (2022) -
CD36 Participates in PrP(106–126)-Induced Activation of Microglia
por: Kouadir, Mohammed, et al.
Publicado: (2012) -
Correction: CD36 Participates in PrP(106–126)-Induced Activation of Microglia
por: Kouadir, Mohammed, et al.
Publicado: (2012) -
The antidiabetic drug troglitazone protects against PrP (106–126)-induced neurotoxicity via the PPARγ-autophagy pathway in neuronal cells
por: Moon, Ji-Hong, et al.
Publicado: (2021)